Barclays’s ZELTIQ Aesthetics, Inc. ZLTQ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-174,263
| Closed | -$9.69M | – | 7235 |
|
|
2017
Q1 | $9.69M | Buy |
174,263
+134,563
| +339% | +$6.75M | 0.01% | 892 |
|
|
2016
Q4 | $1.73M | Buy |
39,700
+38,784
| +4,234% | +$1.56M | ﹤0.01% | 2254 |
|
|
2016
Q3 | $36K | Sell |
916
-132
| -13% | -$4.71K | ﹤0.01% | 5180 |
|
|
2016
Q2 | $29K | Buy |
+1,048
| New | +$29.5K | ﹤0.01% | 5124 |
|
|
2016
Q1 | – | Sell |
-2,878
| Closed | -$81K | – | 6693 |
|
|
2015
Q4 | $81K | Buy |
2,878
+2,121
| +280% | +$67K | ﹤0.01% | 4539 |
|
|
2015
Q3 | $24K | Sell |
757
-2,552
| -77% | -$84.5K | ﹤0.01% | 5382 |
|
|
2015
Q2 | $96K | Buy |
3,309
+2,436
| +279% | +$73.5K | ﹤0.01% | 4714 |
|
|
2015
Q1 | $26K | Sell |
873
-783
| -47% | -$25K | ﹤0.01% | 5701 |
|
|
2014
Q4 | $45K | Sell |
1,656
-23,382
| -93% | -$609K | ﹤0.01% | 5811 |
|
|
2014
Q3 | $551K | Buy |
25,038
+24,458
| +4,217% | +$484K | ﹤0.01% | 3870 |
|
|
2014
Q2 | $9K | Sell |
580
-11,467
| -95% | -$196K | ﹤0.01% | 6905 |
|
|
2014
Q1 | $229K | Buy |
12,047
+5,245
| +77% | +$102K | ﹤0.01% | 4658 |
|
|
2013
Q4 | $122K | Sell |
6,802
-3,624
| -35% | -$51.8K | ﹤0.01% | 5466 |
|
|
2013
Q3 | $94K | Buy |
10,426
+8,794
| +539% | +$65.3K | ﹤0.01% | 5663 |
|
|
2013
Q2 | $11K | Buy |
+1,632
| New | +$7.76K | ﹤0.01% | 7117 |
|
Other funds holding ZLTQ
Barclays's ZLTQ Position: Q2 2017 in Review
Barclays sold out of ZELTIQ Aesthetics, Inc. (ZLTQ) in Q2 2017, closing a stake of 174,263 shares — an estimated $9.69M sold.
Barclays first reported a position in ZLTQ in Q2 2013 and held it in 15 quarters. The position peaked at $9.69M in Q1 2017. 2 funds tracked by Wall St. Rank hold ZLTQ as of Q2 2017.
- Barclays reported no remaining ZELTIQ Aesthetics, Inc. position as of Q2 2017 after selling out during the quarter.
- Barclays sold 174,263 ZELTIQ Aesthetics, Inc. shares in Q2 2017, an estimated $9.69M.
- Barclays first reported a position in ZELTIQ Aesthetics, Inc. in Q2 2013 and held it in 15 quarters.
- Barclays's ZELTIQ Aesthetics, Inc. position peaked at $9.69M in Q1 2017.
- 2 funds tracked by Wall St. Rank held ZELTIQ Aesthetics, Inc. as of Q2 2017.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.